AstraZeneca pounces on rival Alexion in deal worth £29.5bn
British drugs giant AstraZeneca pounces on rival Alexion in deal worth £29.5bn By Neil Craven, Financial Mail on Sunday Published: 21:56 GMT, 12 December 2020 | Updated: 22:02 GMT, 12 December 2020 British drugs giant AstraZeneca will acquire North American rival Alexion Pharmaceuticals in a deal worth $39billion (£29.5billion), it was announced yesterday. The deal … Read more